Stromal vascular fraction cells for the treatment of knee osteoarthritis: a planned clinical trial.
Phase of Trial: Phase I
Latest Information Update: 01 Aug 2014
At a glance
- Drugs Stromal vascular fraction (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions
- Sponsors IntelliCell BioSciences
- 01 Aug 2014 IntelliCell BioSciences has filed its pre-IND with the FDA for this trial, according to a media release.
- 12 Apr 2014 New trial record